日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nomogram for Predicting Pancreatic Pseudocyst in Hypertriglyceridemic Acute Pancreatitis: A Retrospective Cohort Study

用于预测高甘油三酯血症急性胰腺炎患者胰腺假性囊肿的列线图:一项回顾性队列研究

Qi, Rui; Zhong, Jinzhi; Wang, Hebin; Li, Jing; Xu, Jie; Yang, Maohui; Luo, Renying; Liu, Zuofeng; Wang, Hao; Cheng, Lve

Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis.

靶向 FDFT1 可减少胆固醇和胆汁酸的产生,并通过 HNF4A/ALDOB/AKT1 轴延缓肝细胞癌的进展

Cai Dong, Zhong Guo-Chao, Dai Xin, Zhao Zhibo, Chen Menglin, Hu Jiejun, Wu Zhenru, Cheng Lve, Li Shengwei, Gong Jianping

Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma.

整合生物信息学和实验验证,揭示一种新的 VRK 评分作为肝细胞癌的预后和治疗生物标志物。

Fu Zhihao, Liu Dufei, Chen Menglin, Zhong Guochao, Zhao Zhibo, Gong Junhua, Dai Xin, Hu Jiejun, Jia Degong, Cheng Lve, Cai Dong, Gong Jianping

Nomogram for Predicting Sepsis After Percutaneous Transhepatic Cholangioscopic Lithotripsy

经皮经肝胆道镜碎石术后脓毒症预测列线图

Cheng, Lve; Ding, Xiong; Liu, Jie; Shi, Mengjia; Huang, Shijia; Niu, Junwei; Li, Shengwei; Cheng, Yao

Development and validation of a prediction model for cholangitis after percutaneous transhepatic cholangioscopic lithotripsy

经皮经肝胆管镜碎石术后胆管炎预测模型的建立与验证

Cheng, Lve; Li, Junke; Li, Qujin; Ding, Xiong; Liu, Jie; Shi, Mengjia; Huang, Shijia; Niu, Junwei; Li, Shengwei; Cheng, Yao

Risk Factors for Systemic Inflammatory Response Syndrome After Percutaneous Transhepatic Cholangioscopic Lithotripsy

经皮经肝胆道镜碎石术后全身炎症反应综合征的危险因素

Cheng, Lve; Niu, Junwei; Cheng, Yao; Liu, Jie; Shi, Mengjia; Huang, Shijia; Ding, Xiong; Li, Shengwei